Acharya Balkrishna - Search Results

Year	Number of Results
2009	2
2010	5
2011	5
2012	6
2013	4
2014	5
2015	3
2016	4
2017	3
2018	6
2019	15
2020	20
2021	26
2022	35
2023	5

1

Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients.

Devpura G, Tomar BS, Nathiya D, Sharma A, Bhandari D, Haldar S, Balkrishna A, Varshney A. Devpura G, et al. Among authors: balkrishna a. Phytomedicine. 2021 Apr;84:153494. doi: 10.1016/j.phymed.2021.153494. Epub 2021 Feb 4. Phytomedicine. 2021. PMID: 33596494 Free PMC article. Clinical Trial.

2

A selective review of dharana and dhyana in healthy participants.

Telles S, Singh N, Gupta RK, Balkrishna A. Telles S, et al. Among authors: balkrishna a. J Ayurveda Integr Med. 2016 Oct-Dec;7(4):255-260. doi: 10.1016/j.jaim.2016.09.004. Epub 2016 Nov 23. J Ayurveda Integr Med. 2016. PMID: 27889426 Free PMC article. Review.

3

Tinospora cordifolia-associated hepatotoxicity has been scientifically misconstrued, in haste.

Balkrishna A, Bhattacharya K, Sinha S, Dev R, Srivastava J, Haldar S, Varshney A. Balkrishna A, et al. Hepatol Commun. 2022 Nov;6(11):3273-3274. doi: 10.1002/hep4.2050. Epub 2022 Jul 19. Hepatol Commun. 2022. PMID: 35852310 Free PMC article. No abstract available.

4

A systematic review on traditional, ayurvedic, and herbal approaches to treat solar erythema.

Balkrishna A, Singh S, Srivastava D, Mishra S, Sharma S, Mishra R, Arya V. Balkrishna A, et al. Int J Dermatol. 2022 May 29. doi: 10.1111/ijd.16231. Online ahead of print. Int J Dermatol. 2022. PMID: 35643834 Review.

5

A PubMed-Based Exploration of the Course of Yoga Research from 1948 to 2020.

Chetry D, Telles S, Balkrishna A. Chetry D, et al. Among authors: balkrishna a. Int J Yoga Therap. 2021 Jan 1;31(1):Article_22. doi: 10.17761/2021-D-21-00017. Int J Yoga Therap. 2021. PMID: 34727183 Review.

6

Unveiling Novel Therapeutic Drug Targets and Prognostic Markers of Triple Negative Breast Cancer.

Balkrishna A, Mittal R, Arya V. Balkrishna A, et al. Curr Cancer Drug Targets. 2021;21(11):907-918. doi: 10.2174/1568009621666210908113010. Curr Cancer Drug Targets. 2021. PMID: 34503412 Review.

7

Molecular Insights of Plant Phytochemicals Against Diabetic Neuropathy.

Balkrishna A, Pathak R, Bhatt S, Arya V. Balkrishna A, et al. Curr Diabetes Rev. 2022 Aug 25. doi: 10.2174/1573399819666220825124510. Online ahead of print. Curr Diabetes Rev. 2022. PMID: 36028963

8

Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer.

Balkrishna A, Mittal R, Arya V. Balkrishna A, et al. Curr Cancer Drug Targets. 2021;21(2):153-162. doi: 10.2174/1568009620999201103201626. Curr Cancer Drug Targets. 2021. PMID: 33155912 Review.

9

Mechanistic Paradigms of Natural Plant Metabolites as Remedial Candidates for Systemic Lupus Erythromatosus.

Balkrishna A, Thakur P, Singh S, Chandra Dev SN, Varshney A. Balkrishna A, et al. Cells. 2020 Apr 22;9(4):1049. doi: 10.3390/cells9041049. Cells. 2020. PMID: 32331431 Free PMC article. Review.

10

Phytoantioxidant Functionalized Nanoparticles: A Green Approach to Combat Nanoparticle-Induced Oxidative Stress.

Balkrishna A, Kumar A, Arya V, Rohela A, Verma R, Nepovimova E, Krejcar O, Kumar D, Thakur N, Kuca K. Balkrishna A, et al. Oxid Med Cell Longev. 2021 Oct 26;2021:3155962. doi: 10.1155/2021/3155962. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34737844 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results